Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIORESORBABLE SCAFFOLDS INDUSTRY
2.1 Summary about Bioresorbable Scaffolds Industry
2.2 Bioresorbable Scaffolds Market Trends
2.2.1 Bioresorbable Scaffolds Production & Consumption Trends
2.2.2 Bioresorbable Scaffolds Demand Structure Trends
2.3 Bioresorbable Scaffolds Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Metallic Bioresorbable Scaffolds
4.2.2 Polymer Bioresorbable Scaffolds
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Coronary Artery Disease
4.3.2 Coronary Artery Bypass Grafting (CABG)
4.3.3 Peripheral Arterial Disease
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Metallic Bioresorbable Scaffolds
5.2.2 Polymer Bioresorbable Scaffolds
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Coronary Artery Disease
5.3.2 Coronary Artery Bypass Grafting (CABG)
5.3.3 Peripheral Arterial Disease
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Metallic Bioresorbable Scaffolds
6.2.2 Polymer Bioresorbable Scaffolds
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Coronary Artery Disease
6.3.2 Coronary Artery Bypass Grafting (CABG)
6.3.3 Peripheral Arterial Disease
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Metallic Bioresorbable Scaffolds
7.2.2 Polymer Bioresorbable Scaffolds
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Coronary Artery Disease
7.3.2 Coronary Artery Bypass Grafting (CABG)
7.3.3 Peripheral Arterial Disease
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Metallic Bioresorbable Scaffolds
8.2.2 Polymer Bioresorbable Scaffolds
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Coronary Artery Disease
8.3.2 Coronary Artery Bypass Grafting (CABG)
8.3.3 Peripheral Arterial Disease
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Metallic Bioresorbable Scaffolds
9.2.2 Polymer Bioresorbable Scaffolds
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Coronary Artery Disease
9.3.2 Coronary Artery Bypass Grafting (CABG)
9.3.3 Peripheral Arterial Disease
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Laboratories
10.1.2 Amaranth Medical, Inc.
10.1.3 Arterial Remodeling Technologies SA
10.1.4 BIOTRONIK SE & Co. KG
10.1.5 Elixir Medical Corp.
10.1.6 Kyoto Medical Planning Co., Ltd.
10.2 Bioresorbable Scaffolds Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Laboratories
10.2.2 Amaranth Medical, Inc.
10.2.3 Arterial Remodeling Technologies SA
10.2.4 BIOTRONIK SE & Co. KG
10.2.5 Elixir Medical Corp.
10.2.6 Kyoto Medical Planning Co., Ltd.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Bioresorbable Scaffolds Product Type Overview
Table Bioresorbable Scaffolds Product Type Market Share List
Table Bioresorbable Scaffolds Product Type of Major Players
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Amaranth Medical, Inc.
Table Brief Introduction of Arterial Remodeling Technologies SA
Table Brief Introduction of BIOTRONIK SE & Co. KG
Table Brief Introduction of Elixir Medical Corp.
Table Brief Introduction of Kyoto Medical Planning Co., Ltd.
Table Products & Services of Abbott Laboratories
Table Products & Services of Amaranth Medical, Inc.
Table Products & Services of Arterial Remodeling Technologies SA
Table Products & Services of BIOTRONIK SE & Co. KG
Table Products & Services of Elixir Medical Corp.
Table Products & Services of Kyoto Medical Planning Co., Ltd.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Bioresorbable Scaffolds Market Forecast (Million USD) by Region 2021f-2026f
Table Global Bioresorbable Scaffolds Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Bioresorbable Scaffolds Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Bioresorbable Scaffolds Market Forecast (Million USD) Share by Demand 2021f-2026f